Loading clinical trials...
Loading clinical trials...
This is a 3-part study. In Parts A and B, the main purpose is to evaluate the safety and tolerability of the study drug known as LY3561774 in participants with dyslipidemia (high blood fat levels). Ho...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eli Lilly and Company
NCT04634591 · Obesity, Diabetes Mellitus, and more
NCT06496243 · Dyslipidemias
NCT06526273 · Type 2 Diabetes, Hypertension, and more
NCT07308314 · Chronic Disease, Chronic Disease Management, and more
NCT06380322 · Hypertension, Type 2 Diabetes, and more
Altasciences Clinical Los Angeles, Inc
Cypress, California
Collaborative Neuroscience Research, LLC
Long Beach, California
Qps-Mra, Llc
South Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions